Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the
lung. J Thorac Cardiovasc Surg 1972; 64: 413-421.
Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the
lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural,
immunohistochemical, and flow cytometry study of 35 cases. Am J Surg Pathol 1991; 15:
529-53.
Travis WD, Colby TV. The need for a new classification of lung and
pleural tumors. In, Brambilla E and Brambilla C. Eds. Lung tumors: fundamental biology and
clinical management. Lung Marcel Dekker, Inc., New York, 1988 (in press).
Gosney JR. Endocrine pathology of the lung. In Recent Advances in
Histopathology, nº 16. Eds PP Antony, RNM McSween. Churchill-Livinstone 1994.
Colby TV, Koss MN, Travis WD. Tumors of the lower respiratory tract.
Atlas of Tumor Pathology, AFIP, third series, Washington DC, 1995.
Gould VE, Linnoila RI, Memoli VA, Warren WH. Neuroendocrine components
of the bronchopulmonary tract: hyperplasias, displasias, and neoplasms. Lab Invest 1983;
49: 519-537.
Grote TH, Macom WR, Davis B, Greco FA, Johnson DH. Atypical carcinoid of
the lung. A distinct clinicopathologic entity. Chest 1988; 93: 370-375.
Paladugu RR, Benfield JR, Pak PR, Ross RK, Teplitz RL. Bronchopulmonary
Kulchitzky cell carcinomas. A new classifiaction scheme for typical and atypical
carcinoids. Cancer 1985; 55: 1303-11.
Aranda FI. Metástasis suprarrenales por tumor carcinoide atípico
bronquial productor de ACTH. Patología 1996; 29:81-83.
Rusch VW, Klimstra DS, Venkatraman ES. Molecular markers help
characterize neuroendocrine lung tumors. Ann Thorac Surg 1996; 62: 798-810.
Roncalli M, Doglioni C, Springall DR, et al. Abnormal p53 expression in
lung neuroendocrine tumors. Diagnostic and prognostic implications. Diagn Mol Pathol 1992;
1: 129-35.
Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N,
Bakker A, Guinee DG, Koss M, Travis WD. Analysis of p53, k-ras, and C-raf-1 in pulmonary
neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J
Pathol 1996; 148: 1531-41.
Coppola D, Clarke M, Landreneau R, Weyant RJ, Cooper D, Yousem SA.
Bcl-2, p53, and cd44v6 isoform expression in neuroendocrine tumors of the lung. Mod Pathol
1996; 9: 484-90.
Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla Palma
P, Doglioni C. Tumor suppressor gene products, proliferation, and differentiation markers
in lung neuroendocrine neoplasms. J Pathol 1992; 166; 343-350.
Cagle PT, El-Naggar AK, Xu H-J, Hu S-X, Benedict WF. Differential
retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential
diagnostic implications. Am J Pathol 1997; 150: 393-400.
Jiang S-X, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T. Bcl-2
protein expression in lung cancer and close correlation with neuroendocrine
differentiation. Am J Pathol 1996; 148: 837-46.
El-Naggar AK, Ballance W, Karim FW, et al. Typical and atypical
bronchopulmonary carcinoids. A clinicopathologic and flow cytometric study. Am J Clin
Pathol 1991; 95: 828-34.
Jones DJ, Hasleton PS, Moore M. DNA ploidy in bronchopulmonary
carcinoid tumors. Thorax 1988; 43: 195-9.
Jiang S-X, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H. Large
cell neuroendocrine carcinoma of the lung. A Histologic and immunohistochemical study of
22 cases. Am J Surg Pathol 1998; 22: 526-37.
Burnett RA, Howatson SR, Lang S, et al. Observer variability in
histopathological reporting of non-small cell lung carcinoma on bronchial biopsy
specimens. J Clin Pathol 1996; 49: 130-3.
Guinee DG, Fishback NF, Koss MN, et al. The spectrum of
immunohistochemcial staining of small-cell lung carcinoma in specimens from transbronchial
and open-lung biopsies. Am J Clin Pathol 1994; 102: 406-14.
Kaufmann O, Georgi T, Dietel M. Utility of 123C3 monoclonal antibody
against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum
Pathol 1997: 28: 1373-8.
Alkan S, Diaz J, Baekey P. bcl-2 is commonly expressed in small cell
carcioma of lung. Am J Clin Pathol 1994; 102:526 (abstract).
Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G. Small cell carcinomas
of the lung express the bcl2 protein. Am J Pathol 1994; 145: 1036-40.
Gazdar AF. Molecular markers for diagnosis and prognosis of lung
cancer. Cancer 1992; 69: 1592-9.
Funa K, Steinholtz L, Nou E, Bergh J. Increased expression of N-myc in
human small cell lung cancer biopsies predicts lack of response to chemotherapy and poor
prognosis. Am J Clin Pathol 1987; 88: 216-20.
Hurr K, Kemp B, Silver SA, El-Naggar AK. Microsatellite alteration at
chromosome 3p loci in neuroendocrine lung tumors. Histogenetic and clinical relevance. Am
J Pathol 1996; 1996; 149: 613-20.
Linnoila RI, Mulshine JL, Steinberg SM, Funa K, Matthews MJ, Cotelingam
JD, Gazdar AF. Neuroendocrine differentiation in endocrine and nonendocrine lung
carcinomas. Am J Clin Pathol 1988; 90: 641-52.
Schleusener JT, Tazelaar HD, Jung S, et al. Neuroendocrine
differentiation is an independent prognostic factor in chemotherapy-treated nonsamll cell
lung carcinoma. Cancer 1996; 77: 1284-91.
